The latest issue of the Alimentary Pharmacology & Therapeutics investigates the implications for serological testing and vaccination guidelines for prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators.

Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel disease, reports the latest issue of the Inflammatory Bowel Disease.